Latest News about STIM
Recent news which mentions STIM
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
From Benzinga
From Benzinga
From Benzinga
64 Biggest Movers From Yesterday
May 05, 2021
From Benzinga
Tickers
STIM
From Motley Fool
Mid-Afternoon Market Update: Nasdaq Tumbles 300 Points; Neuronetics Shares Spike Higher
May 04, 2021
From Benzinga
From Benzinga
Mid-Day Market Update: Maxar Technologies Falls After Q1 Results; BioLineRx Shares Climb
May 04, 2021
From Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
May 04, 2021
From Benzinga
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
May 04, 2021
From Benzinga
Earnings Scheduled For May 4, 2021
May 04, 2021
From Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
From Benzinga
The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split
April 15, 2021
From Benzinga
Neuronetics, Inc. (STIM) Q4 2020 Earnings Call Transcript
March 03, 2021
Tickers
STIM
From Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 02, 2021
From Benzinga
From Benzinga
Earnings Scheduled For March 2, 2021
March 02, 2021
From Benzinga
The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
February 27, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 08, 2021
From Benzinga
The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO
January 29, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 28, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 22, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Friday
January 22, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 22, 2021
January 22, 2021
From Benzinga
The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa
January 22, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
January 21, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.